CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2021	Dec. 31, 2020	Dec. 26, 2019
OPERATING ACTIVITIES
Net earnings (loss)	$ (43,293)	$ (124,866)	$ 42,115
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:
Losses on investments in joint ventures	92	1,539	274
Distributions from joint ventures	0	0	200
Loss (gain) on disposition of property, equipment and other assets	(3,163)	(856)	1,149
Impairment charges	5,766	24,676	1,874
Depreciation and amortization	72,127	75,052	72,277
Amortization of debt issuance costs and debt discount	2,198	2,235	285
Share-based compensation	9,316	4,385	3,523
Deferred income taxes	(15,843)	(38,836)	9,111
Other long-term obligations	1,689	2,969	1,011
Contribution of the Company’s stock to savings and profit-sharing plan	1,011	1,315	1,181
Changes in operating assets and liabilities:
Accounts receivable	(22,055)	23,106	(3,781)
Government grants receivable	578	(4,913)	0
Other assets	(2,255)	3,476	1,102
Operating leases	(5,325)	9,185	(3,355)
Accounts payable	21,501	(32,131)	9,733
Income taxes	8,508	1,467	67
Taxes other than income taxes	1,258	(2,305)	1,664
Accrued compensation	12,841	(10,422)	508
Other accrued liabilities	1,300	(3,630)	2,541
Total adjustments	89,544	56,312	99,364
Net cash provided by (used in) operating activities	46,251	(68,554)	141,479
INVESTING ACTIVITIES
Capital expenditures	(17,082)	(21,363)	(64,086)
Acquisition of theatres, net of cash acquired and working capital assumed	0	0	(30,081)
Proceeds from disposals of property, equipment and other assets	22,145	4,485	22
Capital contribution in joint venture	(2,427)	(28)	0
Proceeds from sale of trading securities	377	5,184	0
Purchase of trading securities	(3,080)	(801)	0
Life insurance premium reimbursement	11,411	0	0
Other investing activities	(461)	450	199
Net cash provided by (used in) investing activities	10,883	(12,073)	(93,946)
Debt transactions:
Proceeds from borrowings on revolving credit facility	178,500	221,500	335,000
Repayment of borrowings on revolving credit facility	(178,500)	(302,500)	(333,000)
Proceeds from short-term borrowings	0	90,800	0
Repayment on short-term borrowings	(40,346)	(2,955)	0
Proceeds from convertible senior notes	0	100,050	0
Principal payments on long-term debt	(10,717)	(9,447)	(24,620)
Proceeds received from PPP loans expected to be repaid	0	3,424	0
Proceeds received from borrowing on insurance policy	6,700	0	0
Principal payments on finance lease obligations	(2,774)	(2,007)	(2,544)
Debt issuance costs	(208)	(7,560)	0
Equity transactions:
Treasury stock transactions, except for stock options	(417)	(534)	(702)
Exercise of stock options	594	379	1,520
Capped call transactions	0	(16,908)	0
Dividends paid	0	(5,145)	(19,311)
Distributions to noncontrolling interest	0	0	(185)
Net cash provided by (used in) financing activities	(47,168)	69,097	(43,842)
Net increase (decrease) in cash, cash equivalents and restricted cash	9,966	(11,530)	3,691
Cash, cash equivalents and restricted cash at beginning of year	14,088	25,618	21,927
Cash, cash equivalents and restricted cash at end of year	24,054	14,088	25,618
Supplemental Information:
Change in accounts payable for additions to property and equipment	$ 1,122	$ (4,081)	$ 2,185